» Articles » PMID: 35277779

Antigenic and Conserved Peptides from Diverse Helicobacter Pylori Antigens

Overview
Journal Biotechnol Lett
Date 2022 Mar 12
PMID 35277779
Authors
Affiliations
Soon will be listed here.
Abstract

Since the revolutionary finding of Helicobacter pylori as a common bacterial infection, that a high research effort for its eradication has been conducted. Epitope based-vaccine presents advantages over protein-based, as they can be designed to contain epitopes from diverse proteins, therefore, more easily representing the immune-variability of the bacterial population, while minimizing the toxicity associated to some whole proteins. In the present work, an iterative method, to design antigenic and conserved B-epitopes from diverse virulent factors of H. pylori, was established. The method considered the trade-off between epitopes antigenicity and conservation among the bacterial population. For the method validation, five virulent factors from H. pylori were selected. From each virulent factor, two epitopes were predicted, each with twelve residues of aminoacids. The corresponding ten peptides were synthesised and evaluated by enzyme-linked immunosorbent assay using polyclonal antibodies raised against a specific H. pylori strain. All ten peptides were recognised by the antibodies and were consequently antigenic and conserved. This result could strongly contribute to the design of a multivalent epitope-based vaccine, representing the immunogenetic variability within the bacterial population, leading to a sustained and effective immunogenic protection.

Citing Articles

Chitosan Nanoparticles for Enhanced Immune Response and Delivery of Multi-Epitope Vaccines in a BALB/c Mouse Model.

Amaral R, Concha T, Vitor J, Almeida A, Calado C, Goncalves L Pharmaceutics. 2025; 17(1).

PMID: 39861778 PMC: 11768296. DOI: 10.3390/pharmaceutics17010132.


Hp0521 inhibited the virulence of 26,695 strain via regulating CagA expression.

Yu M, Xu M, Shen Y, Liu Y, Xu C, Feng T Heliyon. 2023; 9(7):e17881.

PMID: 37539313 PMC: 10395286. DOI: 10.1016/j.heliyon.2023.e17881.


How Long Will It Take to Launch an Effective Vaccine for Humans?.

Li S, Zhao W, Xia L, Kong L, Yang L Infect Drug Resist. 2023; 16:3787-3805.

PMID: 37342435 PMC: 10278649. DOI: 10.2147/IDR.S412361.


A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant.

He C, Yang J, Hong W, Chen Z, Peng D, Lei H Nat Commun. 2022; 13(1):5459.

PMID: 36115859 PMC: 9482656. DOI: 10.1038/s41467-022-33209-9.


Infection in a Pediatric Population from Romania: Risk Factors, Clinical and Endoscopic Features and Treatment Compliance.

Rosu O, Gimiga N, Stefanescu G, Anton C, Paduraru G, Tataranu E J Clin Med. 2022; 11(9).

PMID: 35566557 PMC: 9099726. DOI: 10.3390/jcm11092432.

References
1.
Cover T, Blaser M . Helicobacter pylori in health and disease. Gastroenterology. 2009; 136(6):1863-73. PMC: 3644425. DOI: 10.1053/j.gastro.2009.01.073. View

2.
Bai Y, Zhang Y, Chen Y, Jin J, Zhang Z, Zhou D . Cloning and expression and immunogenicity of Helicobacter pylori BabA2 gene. World J Gastroenterol. 2004; 10(17):2560-2. PMC: 4572163. DOI: 10.3748/wjg.v10.i17.2560. View

3.
Goh K, Chan W, Shiota S, Yamaoka Y . Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter. 2011; 16 Suppl 1:1-9. PMC: 3719046. DOI: 10.1111/j.1523-5378.2011.00874.x. View

4.
Voland P, Weeks D, Marcus E, Prinz C, Sachs G, Scott D . Interactions among the seven Helicobacter pylori proteins encoded by the urease gene cluster. Am J Physiol Gastrointest Liver Physiol. 2002; 284(1):G96-G106. DOI: 10.1152/ajpgi.00160.2002. View

5.
Kusters J, Van Vliet A, Kuipers E . Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006; 19(3):449-90. PMC: 1539101. DOI: 10.1128/CMR.00054-05. View